RECORD #651577
587821856 | TMEAH | 81145550 | | 6445227 | 9/25/2006 12:00:00 AM | CHF exacerbation | | DIS | Admission Date: 5/25/2006 Report Status:
Discharge Date: 5/15/2006
****** FINAL DISCHARGE ORDERS ******
KAI , KEITH 033-09-86-6
O A Do
Service: CAR
DISCHARGE PATIENT ON: 2/2/06 AT 03:00 PM
CONTINGENT UPON HO evaluation
WILL D/C ORDER BE USED AS THE D/C SUMMARY: YES
Attending: WENSKOSKI , STANTON SID , M.D.
CODE STATUS:
Full code
DISPOSITION: Home w/ services
DISCHARGE MEDICATIONS:
ECASA 81 MG PO DAILY Starting Today ( 0/30 )
Override Notice: Override added on 11/21/06 by
BRINKMANN , ROLANDO , M.D.
on order for COUMADIN PO ( ref # 906162162 )
POTENTIALLY SERIOUS INTERACTION: ASPIRIN &amp; WARFARIN
Reason for override: ok
LIPITOR ( ATORVASTATIN ) 40 MG PO BEDTIME
Alert overridden: Override added on 2/2/06 by :
POTENTIALLY SERIOUS INTERACTION: ERYTHROMYCIN &amp;
ATORVASTATIN CALCIUM Reason for override: home
DIGOXIN 0.25 MG PO DAILY Starting Today ( 0/30 )
Override Notice: Override added on 11/21/06 by
HEIMERDINGER , NOEL , M.D.
on order for ERYTHROMYCIN OPHTHALMIC OINTMENT OU ( ref
# 140719352 ) SERIOUS INTERACTION: DIGOXIN &amp; ERYTHROMYCIN
Reason for override: ok
LASIX ( FUROSEMIDE ) 80 MG PO DAILY Starting IN AM ( 0/30 )
INSULIN NPH HUMAN 40 UNITS QAM; 30 UNITS QPM SC
40 UNITS QAM 30 UNITS QPM
IMDUR ER ( ISOSORBIDE MONONITRATE ( SR ) ) 30 MG PO DAILY
Food/Drug Interaction Instruction
Give on an empty stomach ( give 1hr before or 2hr after
food )
LISINOPRIL 10 MG PO DAILY
Alert overridden: Override added on 2/2/06 by :
POTENTIALLY SERIOUS INTERACTION: SPIRONOLACTONE &amp;
LISINOPRIL
POTENTIALLY SERIOUS INTERACTION: POTASSIUM CHLORIDE &amp;
LISINOPRIL
POTENTIALLY SERIOUS INTERACTION: POTASSIUM CHLORIDE &amp;
LISINOPRIL Reason for override: MD aware
TOPROL XL ( METOPROLOL SUCCINATE EXTENDED RELEASE )
25 MG PO DAILY Starting IN AM ( 0/30 )
Food/Drug Interaction Instruction
Take consistently with meals or on empty stomach.
Number of Doses Required ( approximate ): 1
ALDACTONE ( SPIRONOLACTONE ) 12.5 MG PO DAILY
Food/Drug Interaction Instruction Give with meals
Override Notice: Override added on 0/12/06 by
KRIEG , OLEN , M.D.
on order for LISINOPRIL PO 10 MG QD ( ref # 445027351 )
POTENTIALLY SERIOUS INTERACTION: SPIRONOLACTONE &amp;
LISINOPRIL Reason for override: aware
Previous override information:
Override added on 11/21/06 by GLAZNER , LORENZO , M.D.
POTENTIALLY SERIOUS INTERACTION: LISINOPRIL &amp;
SPIRONOLACTONE
SERIOUS INTERACTION: POTASSIUM CHLORIDE &amp; SPIRONOLACTONE
Reason for override: ok
DIET: Fluid restriction
DIET: House / Low chol/low sat. fat
DIET: House / ADA 1800 cals/dy
ACTIVITY: Resume regular exercise
FOLLOW UP APPOINTMENT( S ):
Dr. Chauncey Patock ( CH Cardiology ) 10/7/06 at 4:40 pm scheduled ,
Dr. Burl Banowski ( PCP ) to be seen in next 2 weeks ,
Talpaz Cum-ope Enwill Medical Center Endocrinology -you will be contacted on monday 9/11 for an appointmen ,
ALLERGY: Penicillins
ADMIT DIAGNOSIS:
CHF exacerbation
PRINCIPAL DISCHARGE DIAGNOSIS ;Responsible After Study for Causing Admission )
CHF exacerbation
OTHER DIAGNOSIS;Conditions , Infections , Complications , affecting Treatment/Stay
CARDIOMYOPATHY-EF 35% , ASTHMA , CAD , HTN , hx ETOH ABUSE , INSULIN REQ TYPE
II DM
OPERATIONS AND PROCEDURES:
0/13 Left Heart Catherization
11/23 Right Heart Catherization
Please see hospital course for salient details.
OTHER TREATMENTS/PROCEDURES ( NOT IN O.R. )
none
BRIEF RESUME OF HOSPITAL COURSE:
**CC / ADMIT Dx: SOB
**BRIEF HPI:
45M with non-DCM ( EF25% ) , DM2 , HTN p/w CHF exacerbation / hypoxia ( PND ,
dyspnea , cough , ?chest tightness on AM of admit ) likely 2/2 to dietary
indiscretion and medical noncompliance. Treated with lasix , aldactone ,
ACE , with improvement from NRB to 2L by NC.
**RELEVANT PMHX:
-DCM ( EtOH ) EF 20-25% ( 11/1 ) followed by Dr. Long Stvrestil s/p angiography 1995 with 50% LAD ( no intervention )
-HTN
-DMII
-OSA on CPAP
-Asthma
**ALLERGIES: PCN ( rash )
**HOME MEDS: Lipitor 20 , Dig 0.l25 , ASA , Lasix
80 , Glipizide 5 , Metformin 500 TID , Insulin 70/30 40
QAM/30 QPM , Lisinopril 10 , Toprol 25 , Aldaction 25 , Coumadin 5
**DAILY STATUS/EXAM:
VS 10/2 AF , P70-100 , BP90-110/60-70 , O2 94 on RA PULM:
CTA CV: JVP 8 , distant , RRR , no murmurs noted
ABD: S/NT/ND
EXTR: 1+ edema to mid-calf bilat , warm , 2+ pulses
NEURO: AOx3 , non-focal
**TESTS/PROCEDURES:
0/13 LHC showed worsening 3vd from prior , no intervention
RHC releaved elevated left and right filling pressures , no
transpulmonary gradient.
**CONSULTS: ACE , SS , nutrition
**Hospital Course:
CV/I: Patient was sucessfully ruled out by serial enzymes for a
potential myocardial infarction. The patient was continuedon his home ASA ,
statin , and BB during his hospital course. To rule out concern for ischemia
as a role in the deterioration of his cardiomyopathy , a left heart
catheterization was performed which showed worsening CAD from his prior
study 5 years. The patient has 3vd disease with diffuse lesions in his RT
PDA , RT LV-VR , LAD , Lcx. Given the patient's symptoms and echocardiographic
evidence of cardiomyopathy proceeded the progression of his CAD , it is
likely that his arteriosclerosis was not the primary etiology of his
imparied cardiac performance though may be contributing to his disease at
this time.
CV/P: CXR on admission revealed pulmonary edema. The patient had
an excellent reponse to diuresis on lasix and was weaned to room air on
the day after admission. His home blood pressure medications were
continued , and were well controlled. A right heart catheterization was
performed on 6/29 which showed elevated right and left sided filling
pressures , particularly with a Pcw of 24 and mean RA pressure of 5. The
patient was started on Imdur during this admission. His lisinopril was
continued.
Pt CV/R: Patient is undergoing evaulation for ICD. NO ectopy was noted
during full-time telemetric monitoring.
PULM: His OSA was treated with CPAP at 6 cm. No active asthma rx. No
wheezes on exam.
ENDO: Patient was maintained off his oral medications and placed on
insulin alone. On admission , his blood sugars were in the 300s. His Last
A1C was found to be 9.5. While following his blood sugars , his insulin was
titrated up and drug therapy discontinued. He was discharged with BID NPH
insulin to replace his previous med/insulin regimen. WSRH outpatient
diabetes services follow-up will be arranged for the patient.
HEME: On coumadin with admit INR 1.1. Coumadin was held
during admission and patient instructed to discontinue medication as
outpatient considering no hx of afib , LV throbus , or DVT/clot as well as
questions with medication compliance.
F/E/N: Patient was instructed on proper diabetic and HF diet.
PSYCH/SOCIAL: Hx EtOH abuse , last drink day of admit. LFTs were
unremarkable. Patient
also lives with cocaine-using brother hough pt denies use. UTox was
negative. SMC consult provided listing of Spanish AA meetings. Social work
helped arranged a medical bed for patient at home , and to facilitate his
ability to obtain public housing.
The patient was discharged home in stable condition. Followup appts were
arranged with his cardiologist , Dr. Myles Mahnken Also , outpatient diabetes
management followup will be arranged with the patient by the AHMH Endocrine
service. He was also instructed to make an appt with his PCP within two
weeks. VNA
services have been obtained to teach and assist him in this new medication
changes..
ADDITIONAL COMMENTS: STOP taking your coumadin.
STOP taking your metformin and gliburide.
CHANGE your insulin to NPH insulin 40 units in the morning and 30 units
before bedtime.
DISCHARGE CONDITION: Stable
TO DO/PLAN:
follow-up with your cardiologist as instructed.
No dictated summary
ENTERED BY: CURZI , YONG , M.D. ( SV64 ) 2/2/06 @ 02
****** END OF DISCHARGE ORDERS ******
[report_end]
